v" The authors performed a controlled study of induced hypertension therapy for treatment of experimental stroke in unanesthetized monkeys. Ten control and 10 treated animals were subjected to a 4-hour occlusion of the middle cerebral artery (MCA) by an implanted tourniquet. Neurological status and local cerebral blood flow (CBF) were monitored serially. Local CBF was determined by hydrogen clearance in and around the elevated 20% to 40% by intravenous infusion of phenylephrine hydrochloride. Neuropathological evaluation was performed after about 2 weeks.
since increased cerebral perfusion pressure might enhance flow in ischemic zones, thus leading to improved neurological function. Several clinical studies have reported increased local cerebral blood flow (CBF) or improved neurological status during hypertensive therapy for focal ischemia. 4"~ 7.20.41 However, laboratory studies have failed to show consistent increases in local CBF during induced hypertension and middle cerebral artery (MCA) occlusion. Moreover, deleterious effects have been observed after hypertension coupled with cerebral ischemia. J9'24 Overall, the role of induced hypertension in the therapy of focal cerebral ischemia remains unclear. 3~ To help evaluate this potential mode of therapy for ischemic stroke, we have performed a controlled study in unanesthetized monkeys subjected to focal cerebral ischemia. A model using awake primates was chosen to eliminate the effects of anesthesia and maximize clinical relevance. A moderate ischemic challenge, namely, 4 hours of MCA occlusion, was produced to maximize the chances of demonstrating a favorable therapeutic effect.
Materials and Methods

Twenty-six cynomolgus monkeys (Macaca irus)
were studied. The animals were unselected for sex and weighed between 3.4 and 4.5 kg. All animals underwent a 4-hour occlusion of the MCA; 14 of these were treated with drug-induced hypertension, and 12 served as controls. Several experiments were rejected because of technical inadequacy. Animals were rejected because of subarachnoid bleeding during preparatory surgery (two cases) or for failure to sustain drug-induced hypertension (four animals). Thus, 10 treated and 10 control animals were available for detailed analysis.
Details of this stroke model have been described previously, 7' 23"27 and therefore the method is only summarized here. A preparatory operation was performed under general anesthesia (pentobarbital). Central arte- * The neurological status 2 weeks after occlusion was better in the group treated with induced hypertension, but the improvement did not reach statistical significance.
rial and venous catheters were placed through a femoral approach to monitor blood pressure, blood gases, and central venous pressure, and to infuse fluids and drugs. To measure local CBF, six platinum-iridium electrodes were implanted stereotaxically, five in the right hemisphere (from the caudate nucleus laterally to the cortex) and one in the left. A pressure-sensing device was implanted epidurally in the fight parietal region. The fight MCA was exposed microsurgically via a transorbital approach, and a snare ligature device was implanted around the origin of the MCA for subsequent occlusion.
Monkeys awoke from anesthesia in a standard primate restraining chair. Baseline determinations were carded out to assess neurological status, mean arterial blood pressure (MABP), arterial blood gases, and intracranial pressure (ICP). Local CBF was measured serially by the hydrogen clearance method. 2'2'8' 46 After stable CBF values were obtained, the MCA was occluded for 4 hours with the implanted snare ligature device. Neurological status was graded on a simple scale, as follows:
Grade 0 = no deficit Grade 1 = minimal deficit (mild brachial monoparesis) Grade 2 = moderate deficit (moderate hemiparesis) Grade 3 = severe deficit (hemiplegia and drowsiness) Grade 4 = death. Five to eight determinations of local CBF were performed during the 4-hour occlusion period. The snare ligature was then released, and in each case increased local CBF confirmed restoration of MCA antegrade blood flow. In the treated animals, 30 minutes after the start of MCA occlusion the MABP was raised by 20% to 40% by intravenous infusion of phenylephrine hydrochloride (40 mg in 250 ml normal saline). Druginduced hypertension was maintained for 3 89 hours until just prior to release of the snare ligature. For 24 hours thereafter we performed further serial examinations of neurological status, MABP, blood gases, and local CBF. Animals were then returned to their cages for intermittent neurological assessment.
About 2 weeks after ischemia, the animals were anesthetized with pentobarbital and sacrificed by perfusion S. Hayashi, et al.
fixation with buffered formalin. Brains were fixed, sectioned horizontally, and examined histologically. As described elsewhere, 7'23'27 infarction was evaluated regarding size, extent, character, and relation to CBF electrodes. Infarct size was divided as follows, based upon greatest dimension of the ischemic lesion: 0)no infarct; 1) microscopic infarct; 2) infarct less than 1 cm in greatest dimension; 3)infarct 1 to 2 cm in greatest dimension; and 4) infarct greater than 2 cm in greatest dimension.
Results
Systemic Factors
Arterial blood gases and hematocrit did not differ in the control and treatment groups. The pO2 (84 _+ 5 tonfor the treated group and 99 _+ 7 torr for the control group) and pH (7.41 _+ 0.03 for the treated group and 7.41 __+ 0.04 for the control group) were normal. Determinations of pCO2 revealed a moderate hypocapnia in both groups (28 + 5 torr for the treated group and 29 + 3 torr for the control group), probably related to anxiety-induced hyperventilation. A mild anemia (32.5% _+ 2.1% for the treated group and 35.8% _+ 0.2% for the control group) was present in both groups, reflecting blood loss from the preparatory transorbital surgery.
Except during the infusion of the pressor agent, MABP was similar in the treated and untreated groups (101 ___ 10 torr for the treated animals and 99 +__ 13 torr for the controls). During pressor therapy, MABP was elevated 24 ___ 9 torr. Hypertension was difficult to maintain. Six animals required saline infusion (raising the central venous pressure (CVP) to 10 cm H20) in addition to large doses of phenylephrine to sustain hypertension. Four other animals were excluded from the study when hypertension could not be maintained. In three of these, MABP fell below 80 torr because of cardiac dysrhythmias which were apparently due to the phenylephrine. As the study progressed, we found that dysrhythmia and hypertension could be avoided by pretreatment with saline to raise CVP to 8 to 10 cm H20 with limitation of the phenylephrine dosage.
Neurological Examination
Prior to occlusion of the MCA, all monkeys were neurologically normal. When the snare ligature was tightened, all animals developed neurological deficits (Figs. 1 and 2). in most cases this was a moderate hemiparesis (Grade 2), with deviation of the head and eyes toward the ischemic hemisphere. In several cases the deficit was severe (Grade 3), and in a few it was mild (Grade 1). The neurological status of the treated animals did not differ significantly from that of the untreated group immediately following occlusion (Mann-Whitney U test, z = 0). Data on the neurological status for all animals are presented in Fig. 2 . In the untreated group, the initial deficit remained stable throughout the occlusion in nine of 10 monkeys, and one animal improved a single grade. With the initiation of hypertensive therapy, five of 10 treated animals improved a single grade. In the other five, the deficit remained stable. The improved neurological status of the hypertensive group compared to the control group approached statistical significance (Mann-Whitney U test of the control versus the treated groups, z = 1.60, p _< 0.055). In four treated animals hypertension could not be maintained late in the course of occlusion; all four deteriorated one neurological level. Two of these regained their previous neurological improvement with the reestablishment of hypertension. Upon release of the snare ligature, some animals in both groups showed immediate improvement in their neurological status. One animal in the untreated group deteriorated and died. The final neurological status (2 weeks after ischemia) is presented in Table 1 . The final outcome was better in the treated group, but the improvement did not reach statistical significance.
Cerebral Blood Flow
Determinations of local CBF were available in eight of the untreated monkeys and in 10 of the treated animals. Because the number of electrodes located within the ischemic zone varied from animal to animal, only the electrodes registering a flow at occlusion that was at least 20% lower than the preocclusion flow were included in the data analysis. Mean CBF was obtained by averaging the local CBF values from these electrodes (Fig. 3) .
Mean preocclusion CBF values in the two groups were similar to each other and to previously reported values. 7.23"27 In the untreated group, the average mean preocclusion CBF was 37 + 12 ml/100 gm/min, and in the treated group it was 27 + 16 ml/100 gm/min. Following the onset of occlusion, local CBF decreased in the ischemic hemispheres. At the start of occlusion, mean CBF values were similar in both groups, with the flows in the untreated animals falling to 11 4-5 ml/100 gm/min and the flows in the hypertensive group decreasing to 11 _+ 6 ml/100 gm/min. A slight increase in mean CBF was noted in both groups during the period of occlusion (Table 2) . Flow increased by 31% in the treated animals and by 12.5% in the untreated animals. Differences in flow values between the two groups did not reach statistical significance. However, there was a statistically significant increase in mean CBF in the treated group for early (hypertension) blood flows compared to flows during occlusion (paired t-test, t = 2.64, p < 0.05).
In the four treated animals in which hypertension could not be maintained (Fig. 3) , there was a decrease in mean CBF compared to flow values during hypertension (Table 2 ). In three of these, there were decreases below occlusion flows (-44%).
Following release of MCA occlusion, mean hemispheric blood flows increased compared with flows during occlusion in all cases except one. In the untreated group there was an increase in CBF over the preocclusion flows. This relative hyperperfusion was not as marked in the treated animals.
Pathological Examination
As in prior experiments, cerebral infarcts were concentrated deep in the ischemic hemisphere. The smallest infarcts occurred in the caudate nucleus, putamen, and internal capsule. Medium-sized infarcts extended into the centrum semiovale and insular cortex. Large lesions involved the entire MCA territory of distribution including the opercular cortex. In animals surviving 2 weeks after ischemia, a clear distinction between normal and infarcted tissue permitted accurate sizing of the lesions. Infarct size was hard to judge in animals that died less than 2 weeks after occlusion. In these animals, an estimate of infarct size was made. The mean infarct size tended to be larger in the control group compared to the treated group (Table 3) , but this was not statistically significant.
The character of the infarcts was consistently ischemic. In the animals that died after ischemia, large edematous infarcts were invariably present, but evidence of hemorrhagic infarct or frank hemorrhage was not found. The MCA at the site of occlusion was examined at the time of sacrifice. No evidence of thrombosis was observed.
Correlations
In the ischemic zones, changes in local CBF paralleled changes in MABP. Induced hypertension increased mean CBF in these areas by an average of 40%. However, in the animals in which hypertension could not be maintained and hypotension developed, the mean CBF decreased by 33% from preocclusion values ( Table 2 ). In the nonischemic zones, autoregulation was preserved and CBF remained relatively constant throughout the course of hypertension. Mean preocclusion CBF at these electrodes was 19.6 _+ 12.5 ml/100 gm/min. During induced hypertension the mean CBF was 17.2 _+ 8.1 ml/100 gm/min.
Neurological status in the treated animals was also related to MABP and mean CBF. Five animals improved one neurological grade after the initiation of hypertension and four animals deteriorated one neurological grade during hypotensive episodes.
Although the final neurological status and infarct size did not differ between the treated and untreated groups at a statistically significant level, there was a beneficial tendency of induced hypertension in both of these categories (Tables 1 and 3 ). When the final neurological status was considered in relation to the lowest mean CBF, a significant difference was noted. When the mean CBF did not fall below 10 ml/100 gm/min, the final neurological status was significantly better than when it did fall below this value (Table 4 , Mann-Whitney U test, z = 2.70, p < 0.0035). Six animals with flows greater than 10 ml/100 gm/min were left with no final deficit, and only one died; whereas all animals with flows less than I0 ml/100 gm/min had at least a mild deficit, and five died. Mean CBF of 10 ml/100 gm/min for 4 hours appears to be a threshold for severe ischemic stroke in awake monkeys.
Discussion
Cerebral blood flow is a function of cardiac output (CO) and vascular resistance. It is rational to treat cerebral ischemia with hypertension in an attempt to increase the perfusion pressure. When normal autoregulation is lOSt, 1'36 CBF in the ischemic zone reflects changes in the MABP. Numerous clinical reports have demonstrated the efficacy of hypertensive therapy in the treatment of cerebral ischemia related to: 1)vasospasm secondary to subarachnoid hemorrhage;9.11,14,33 2) aneurysm surgery; 5'~5'24 3) carotid artery occlusion for treatment of cerebral aneurysms and carotid-cavernous fistulas; 1116'4~ 4)carotid and basilar artery thrombosis; 3~ and 5)postangiographic hemiplegia 1''42'43 and other neurosurgical procedures. ~ In laboratory animals subjected to experimental cerebral ischemia, improvement has been noted in CBF, 4"2~ cortical evoked responses, 4"2~ and extracellular potassium concentration. 2~ However, hypertensive therapy for cerebral ischemia is not without risk. Increased flow to an area of infarction may cause hemorrhage or worsening of edema, 19'2432 and side effects of the therapy such as dysrhythmia and cardiac failure are also potentially harmful. 26 An experimental model of focal cerebral ischemia in awake primates has certain advantages, including clinical relevance.I~ Transorbital selective MCA occlusion achieves reversible focal ischemia and avoids the confusing effects of anesthesia. 2~'35 Variability of infarct size, presumably due to differences in collateral circulation, mimics clinical experience. The extent of deficits for the control and experimental groups was similar, and each treated animal served as its own control. The hydrogen clearance method of CBF determination 2"12"18"37"46 allows measurement of both spatial and temporal resolution of focal ischemia. ~8' 46 Difficulty in maintaining hypertension was solved by volume expansion with normal saline to keep the CVP in the range of 8 to 10 cm HzO. Michenfelder and Milde 26 also had difficulty maintaining hypertension with phenylephrine in the three animals that they studied. The use of volume loading in our animals complicates the interpretation of the effects of hypertension. Recent papers have reported the use of volume loading as a method of treating cerebral ischemia, 14'5' 25' 28 and the use of saline introduces the factor hemodilution, also considered to be beneficial for cerebral ischemia. 22"38 However, we observed dramatic clinical responses to the hypertension itself, and there was deterioration in neurological grade with the loss of hypertension.
Beneficial effects of induced hypertension were observed in neurological status, final pathology, and final neurological grade, although none of these reached statistical significance. Cerebral blood flow was significantly increased in the ischemic zone by hypertensive therapy. Changes in neurological status and CBF indicated a strong correlation with changes in blood pressure. Loss of autoregulation in the ischemic zone was demonstrated by the passive changes in CBF in relation to changes in MABP. In the nonischemic areas, however, electrodes registered little change in local CBF in response to changes in MABP, confirming the preservation of autoregulation. Induced hypertension has been shown by other authors to be beneficial in experimental ischemia. Hope, et al., 2~ studied the effects of Aramine (metaraminol)-induced hypertension in baboons subjected to MCA occlusion. They noted a statistically significant improvement in extracellular potassium levels and somatosensory evoked responses to hypertension. As measured by the hydrogen clearance method, CBF was increased, but not to a statistically significant level. Ritchie, et al., 29 and Boisvert, et al., 3 studied the effect of hypertensive therapy in rhesus monkeys undergoing experimental subarachnoid hemorrhage. Hypertension produced increases in CBF and blood vessel caliber.
Various authors have considered thresholds of CBF.
A critical CBF level of 18 ml/100 gm/min has been shown at which electroencephalographic changes take place. 34 Flows below 12 ml/100 gm/min are associated with changes in evoked potentials. 4 Irreversible neurological deficits occur below CBF's of 12 ml/100 gm/ min. 27 Infarction is probably a function of the level and duration of ischemiafl 3 We noted a critical mean CBF level of I0 ml/100 gm/min for 4 hours. Final outcome was significantly better when the mean CBF remained above this value during occlusion. Several cerebrovascular mechanisms may come into play when hypertension modifies ischemia. Davis and Sundt 8 found that decreases in cardiac output that did not affect MABP could significantly lower CBF. By increasing cardiac output at normotensive levels through the use of drugs and intravascular volume expansion, Pritz, et al.,28 were able to reverse ischemic deficits in several patients. Van Dellen and Buchanan 39 were able to improve ischemia by increasing the heart rate. However, Wood, et al., 45 found that raising the cardiac output by volume loading in dogs did not increase CBF when the MABP and hematocrit were not altered. Our data would support the importance of hypertension in increasing flow to ischemic areas, but the relative contributions of increased cardiac output and hypertension cannot be delineated since cardiac output was not measured. Intracranial steal may occur in areas of ischemia, 45 but out data did not identify such changes in relation to hypertension.
Induced hypertension has been shown to be of benefit in the treatment of cerebral ischemia due to vasospasm 5'9'I1"14'15'24'33'42'43 and arterial occlusion. 11'16'31'4~ Our results support the efficacy of hypertension in increasing CBF in areas of ischemia and in improving neurological function when therapy is instituted early in the course of ischemia. Its use in the treatment of cerebral vascular accidents is less clear.
Adverse effects of hypertension in the face of cerebral ischemia have been reported. Several authors have noted an increase in brain edema, leading to rapid deterioration when hypertension was initiated late in the course of ischemia. 19"24 Fisher and Adams 13 advanced the theory of hemorrhagic infarction occurring in areas of reperfusion after embolism. Hemorrhagic infarction has been reported following carotid endarterectomy with hypertension. 6 Many authors have noted critical levels of blood pressure in patients with focal cerebral ischemia, below which neurological dysfunction occurred. 9"tt'24'39 '42'44 Our data clearly confirm the deleterious effects of hypotension during cerebral ischemia.
Summary
In an experimental model of cerebral ischemia in awake primates, hypertension established shortly after occlusion was shown to have a beneficial effect on CBF, infarct size, and neurological status. No hemorrhagic infarctions were observed. Induced hypertension, when S. Hayashi, et al.
instituted early, may be beneficial in the treatment of some cases of cerebral ischemia.
